| Updated COVID‐19 clearance time among patients with cancer in the Delta and Omicron waves ZM Avigan, R Paredes, LS Boussi, BD Lam, ME Shea, MJ Weinstock, ... Cancer Medicine 12 (16), 16869-16875, 2023 | 3 | 2023 |
| Heterogeneity in methods for estimating renal function in anticancer drug development. AB Karol, Y Fujiwara, R Paredes, A Argulian, H Joshi, MD Galsky Journal of Clinical Oncology 42 (16_suppl), e23002-e23002, 2024 | | 2024 |
| Association between somatic mutation pathways and treatment response in patients with biliary tract cancers (BTCs). V Birda, SA Osataphan, J Lyon, R Paredes, AAA Rattani, MLB Peters Journal of Clinical Oncology 42 (16_suppl), e16196-e16196, 2024 | | 2024 |
| Black patient representation in anti-cancer drug development. AB Karol, R Paredes, Y Fujiwara, A Argulian, H Joshi, MD Galsky Journal of Clinical Oncology 42 (16_suppl), e13680-e13680, 2024 | | 2024 |
| Number of subsequent treatments and time to recurrence in hepatocellular carcinoma. JJ Juarez, V Birda, S Sucre, E Garita, K Pacheco-Barrios, R Paredes, ... Journal of Clinical Oncology 42 (3_suppl), 526-526, 2024 | | 2024 |
| 2694. Infectious Complications in CAR-T Cell Therapy Recipients: A Systematic Review and Meta-Analysis M Banegas, P Bindal, MJH Woodbine, P Aggarwal, R Paredes, J Arnason, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2305, 2023 | | 2023 |
| BCMA-Directed CAR-T Cell Therapy Is Associated with a Higher Risk of Infections: A Systematic Review and Meta-Analysis P Bindal, M Banegas, R Paredes, MJ Hernandez, P Aggarwal, ... Blood 142, 6917, 2023 | | 2023 |
| Impact of hospice enrollment timing on overall survival and quality of life indicators in patients with pancreatic ductal adenocarcinoma (PDAC). R Paredes, M Banegas, S Sucre, C Ponce, MLB Peters JCO Oncology Practice 19 (11_suppl), 243-243, 2023 | | 2023 |
| Relación del equivalente de hemoglobina reticulocitaria (Ret-He) con diferentes categorías según la concentración de hemoglobina en candidatos a donar sangre P Aro, R Paredes, R Cornejo, K Laveriano, R Rengifo, C Lezama, ... Acta Médica Peruana 40 (3), 214-221, 2023 | | 2023 |
| Molecular profiling as a predictor of treatment response and survival in unresectable pancreatic ductal adenocarcinoma. R Paredes, M Banegas, S Sucre, C Ponce, AAA Rattani, MLB Peters Journal of Clinical Oncology 41 (16_suppl), e16279-e16279, 2023 | | 2023 |
| Preservation of the Innate Immune Response to Clostridioides difficile Infection in Hospitalized Immunocompromised Patients M Banegas, J Villafuerte-Gálvez, R Paredes, R Sprague, C Barrett, ... Open Forum Infectious Diseases 10 (3), ofad090, 2023 | | 2023 |
| Immunohistochemical and genetic profiles do not predict behavior of mixed hepatocellular intrahepatic cholangiocarcinoma. S Sucre, R Paredes, MLB Peters Journal of Clinical Oncology 41 (4_suppl), 516-516, 2023 | | 2023 |
| MAJOR ARTICLE M Banegas, J Villafuerte-Gálvez, R Paredes, R Sprague, H Xu, Q Lin, ... | | 2023 |
| Uptake in genetic testing in patients with pancreatic cancer with oncologist-driven testing protocol. T King, P Widick, R Paredes, O Klein, J Krejdovsky, NM Tung, MLB Peters Journal of Clinical Oncology 40 (28_suppl), 33-33, 2022 | | 2022 |
| COVID-19 clearance among patients with cancer during the Delta and Omicron waves. ZM Avigan, R Paredes, LS Boussi, B Lam, M Shea, M Weinstock, ... Journal of Clinical Oncology 40 (28_suppl), 42-42, 2022 | | 2022 |
